兰州高级整体女性导尿模型海南腹股沟层次解剖,盐城组合式多功能护理实习模拟人(女性),石家庄胎儿血液循环及胎盘模型（6部件）,西安消化系统模型,合肥男性躯干横断断层解剖模型,萍乡多功能肌肉注射模块,辽宁开放式儿科护理学辅助教学系统

SHANGHAI, March 17 (Xinhua) -- Lenovo Group and a subsidiary of Shanghai Media Group (SMG) signed an agreement on Thursday to create a firm that would provide mobile-Internet video services.BesTV New Media Co., a subsidiary of SMG, owns 51 percent of the venture, named Shanghai Video Cloud Company Limited, while Lenovo owns the remainder. The total investment of both parties in the new firm exceeded 10 million yuan (1.52 million U.S. dollars), according to the agreement.Lenovo is currently the largest personal computer maker in China. BesTV New Media is a provider of Internet Protocol Television (IPTV), mobile television and other forms of new media. 

BEIJING, Feb. 2, (Xinhua) -- All Chinese travelers stranded in Egypt are expected to have been returned to China by Thursday, the start of the Spring Festival, said China's national tourism authorities late Wednesday.As of the Spring Festival Eve, most of the Chinese tourists stranded in Egypt due to the country's nation-wide protests had been flown back to China by chartered planes, according to a statement released by the National Holiday Office, an inter-ministerial agency led by the National Tourism Administration.China had sent a total of eight "special commercial flights" to Cairo, Luxor and Hurghada to bring back Chinese citizens stranded in these cities, and six of the planes had returned, carrying 1,371 people, including those from Hong Kong, according to the Chinese Foreign Ministry.The Spring Festival is the Chinese lunar New Year, a time for family reunions, according to Chinese tradition.The National Holiday Office has also issued warnings about traveling to Australia, as tropical cyclone Yasi was expected to make landfall in northeast Queensland late Wednesday local time.

WASHINGTON, March 22 (Xinhua) -- A long-term study by Greek researchers has shown the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cells in treating people with aggressive forms of multiple sclerosis (MS).The study was published on Tuesday in Neurology, the medical journal of the American Academy of Neurology.For the treatment, chemotherapy drugs are used to kill all of the patient's blood cells, including the immune cells that are believed to be attacking the body's own central nervous system. Bone marrow stem cells removed from the patient are purified and transplanted back into the body, which saves life by replacing the blood cells and also is proposed to "reboot" the immune system.A human embryonic stem cell line derived at Stanford University is seen in this handout photo released to Reuters by the California Institute for Regenerative Medicine, March 9, 2009The study followed 35 people for an average of 11 years after transplant. The study involved people with rapidly progressive MS who had tried a number of other treatments for MS with little or no effect. All were severely disabled by the disease, with an average score of six on a scale of disease activity that ranges from zero being a normal neurological examination to 10 meaning death due to MS.A score of six means able to walk with a cane or crutch; a seven is mainly in a wheelchair. All had worsened by at least one point on the scale in the year prior to the transplant.After the transplants, the probability of participants having no worsening of their disease for 15 years was 25 percent. The probability was higher -- 44 percent -- for those who had active brain lesions, which are a sign of disease activity, at the time of the transplant.For 16 people, symptoms improved by an average of one point on the scale after the transplant, and the improvements lasted for an average of two years. The participants also had a reduction in the number and size of lesions in their brains. Two people (six percent) died from complications related to the transplant at two months and 2-1/2 years post-transplant.Study author Vasilios Kimiskidis, of Aristotle University in Thessaloniki, Greece, noted that more research is needed on this treatment, including studies that compare people receiving the treatment to a control group that does not receive the treatment."Keeping that in mind, our feeling is that stem cell transplants may benefit people with rapidly progressive MS," he said. "This is not a therapy for the general population of people with MS but should be reserved for aggressive cases that are still in the inflammatory phase of the disease."

BEIJING, Feb. 15 (Xinhua) -- Chinese Vice Premier Wang Qishan told a U.S. business delegation Tuesday that China would create a sound environment for business cooperation between the two countries.Praising the contribution of U.S. businesses to the sound development of China-U.S. relations, Wang said more exchanges between business people from the two countries would help promote bilateral trade cooperation.Chinese Vice Premier Wang Qishan (C front) poses for a group photo with members of a visiting U.S. business delegation headed by John Mack, chairman of Morgan Stanley, in Beijing, capital of China, Feb. 15, 2011. Executive chairman of Morgan Stanley and chief delegate John Mack said the U.S. business community would increase exchanges and cooperation with Chinese counterparts and play a positive role in the sound development of bilateral relations.The delegation, composed of the heads of many major U.S. companies, including General Motors, is visiting China from Feb. 13 to 16 for unofficial exchanges with Chinese businesses, including China National Offshore Oil Corporation and CITIC Group, according to the China Council for the Promotion of International Trade.

WASHINGTON, April 29 (Xinhua) -- A U.S. appeals court ruled on Friday that the Obama administration can continue the taxpayer- funding for human embryonic stem cell research.The U.S. Court of Appeals in Washington overturned a preliminary federal court order that would have blocked the U.S. Health and Human Services Department and the National Institutes of Health (NIH) from spending government money on embryonic stem cells research."Today's ruling is a victory for our scientists and patients around the world who stand to benefit from the groundbreaking medical research they're pursuing," said Nicholas Papas, a White House spokesman.U.S. President Barack Obama has been trying to expand government funding for human embryonic stem cells research, saying that years of progress on finding cures for spinal cord injuries, Parkinson's disease and other diseases would be lost without the government support on this field.Opponents have been arguing the research is unacceptable because embryonic stem cells can only be obtained through destroying human embryos.Last August, a federal judge ruled that the government-backed embryonic stem cell research violated the law because embryos were destroyed in the process and it jeopardized the position of researchers using adult stem cells for winning federal grants.The government immediately appealed to the ruling, and the appeals court said the research could continue at the NIH before the judge ruled on the case.